Acesion Pharma
Copenhagen, Denmark· Est. 2010
Develops novel antiarrhythmic drugs for the treatment of atrial fibrillation.
Private Company
Total funding raised: $25M
About
Develops novel antiarrhythmic drugs for the treatment of atrial fibrillation.
Small Molecules
Funding History
1Total raised:$25M
Series B$25MMar 15, 2022